5
H index
3
i10 index
96
Citations
Boston University | 5 H index 3 i10 index 96 Citations RESEARCH PRODUCTION: 9 Articles 12 Papers 3 Chapters RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Rena Marie Conti. | Is cited by: | Cites to: |
| Journals with more than one article published | # docs |
|---|---|
| Journal of Policy Analysis and Management | 2 |
| Journal of Economic Perspectives | 2 |
| PharmacoEconomics | 2 |
| Working Papers Series with more than one paper published | # docs |
|---|---|
| NBER Working Papers / National Bureau of Economic Research, Inc | 12 |
| Year | Title of citing document |
|---|---|
| 2024 | How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?. (2024). Dafny, Leemore ; Ho, Kate ; Kong, Edward. In: American Economic Journal: Economic Policy. RePEc:aea:aejpol:v:16:y:2024:i:3:p:314-46. Full description at Econpapers || Download paper |
| 2025 | Who Pays, Who Benefits? Producer-Insurer Games in Life-Saving Medicines. (2025). Leh, Thomas ; Coculescu, Delia ; Janisch, Maximilian. In: Papers. RePEc:arx:papers:2509.16125. Full description at Econpapers || Download paper |
| 2025 | Effect of Market Entry on Generic Drug Prices: Medicare Data 2007-2022. (2025). Buchmueller, Thomas ; Zuckerman, Rachael ; Bosworth, Arielle ; Sheingold, Steven ; Nguyen, Nguyen Xuan. In: International Journal of Research and Innovation in Social Science. RePEc:bcp:journl:v:9:y:2025:i:1:p:1485-1496. Full description at Econpapers || Download paper |
| 2024 | Relative size distribution of business firms—A QRSE approach. (2024). Sundal, Douhan. In: Economic Modelling. RePEc:eee:ecmode:v:140:y:2024:i:c:s0264999324002049. Full description at Econpapers || Download paper |
| 2025 | Price regulation and competition among on-patent anticancer drugs in Italy. (2025). Mancusi, Maria ; Vassallo, Chiara ; Fiorentino, Francesca ; di Costanzo, Alessandra ; Candelora, Laura ; Caimmi, Michele ; Canali, Beatrice. In: Health Policy. RePEc:eee:hepoli:v:157:y:2025:i:c:s0168851025001046. Full description at Econpapers || Download paper |
| 2024 | Public entry and private prices: New evidence from Indian pharmaceutical markets. (2024). Gupta, Samarth ; Chatterjee, Chirantan. In: Journal of Economic Behavior & Organization. RePEc:eee:jeborg:v:219:y:2024:i:c:p:473-489. Full description at Econpapers || Download paper |
| 2025 | Procurement institutions and essential drug supply in low and middle-income countries. (2025). Zahur, Nahim Bin ; Wang, Lucy Xiaolu. In: Journal of Health Economics. RePEc:eee:jhecon:v:101:y:2025:i:c:s016762962500030x. Full description at Econpapers || Download paper |
| 2024 | Pricing above value: Selling to a market with selection problems. (2024). Boone, Jan. In: Journal of Health Economics. RePEc:eee:jhecon:v:94:y:2024:i:c:s0167629624000134. Full description at Econpapers || Download paper |
| 2025 | Strategic buyer stockpiling in supply chains under uncertain product availability and price fluctuation. (2025). Yan, Xue ; Jin, Shibo ; He, Yong ; Li, Shanshan. In: Omega. RePEc:eee:jomega:v:133:y:2025:i:c:s030504832500009x. Full description at Econpapers || Download paper |
| 2025 | Nothing for something: Marketing cancer drugs to physicians increases prescribing without improving mortality. (2025). Li, Jing ; Daly, Michael ; Carey, Colleen. In: Journal of Public Economics. RePEc:eee:pubeco:v:242:y:2025:i:c:s004727272500009x. Full description at Econpapers || Download paper |
| 2025 | The value of group purchasing: Evidence from the U.S. hospital industry. (2025). Wang, Yanhao ; Lin, Haizhen. In: Journal of Public Economics. RePEc:eee:pubeco:v:247:y:2025:i:c:s0047272725000787. Full description at Econpapers || Download paper |
| 2024 | Competition, value-based prices and incentives to research personalised drugs. (2024). LEVAGGI, ROSELLA. In: Socio-Economic Planning Sciences. RePEc:eee:soceps:v:93:y:2024:i:c:s0038012124000697. Full description at Econpapers || Download paper |
| 2024 | Profits over care? An analysis of the relationship between corporate capitalism in the healthcare industry and cancer mortality in the United States. (2024). Perry, Teresa ; Bernasek, Alexandra. In: Social Science & Medicine. RePEc:eee:socmed:v:349:y:2024:i:c:s0277953624002958. Full description at Econpapers || Download paper |
| 2025 | Navigating payment and policy barriers to gender-affirming care for transmasculine individuals: A qualitative study and policy assessment. (2025). Grov, Christian ; Zewde, Naomi ; D'Angelo, Alexa B ; Dearolf, Michelle ; Restar, Arjee ; Tsui, Emma K. In: Social Science & Medicine. RePEc:eee:socmed:v:366:y:2025:i:c:s0277953624011201. Full description at Econpapers || Download paper |
| 2024 | Price negotiation and pricing of anticancer drugs in China: An observational study. (2024). Pan, Jay ; Lu, Hao ; Lan, Tianjiao ; Zhou, Jing. In: PLOS Medicine. RePEc:plo:pmed00:1004332. Full description at Econpapers || Download paper |
| 2025 | Pharmaceutical Regulation and Incentives for Innovation in an International Perspective. (2025). Dubois, Pierre. In: TSE Working Papers. RePEc:tse:wpaper:131002. Full description at Econpapers || Download paper |
| Year | Title | Type | Cited |
|---|---|---|---|
| 2015 | Pricing in the Market for Anticancer Drugs In: Journal of Economic Perspectives. [Full Text][Citation analysis] | article | 46 |
| 2015 | Pricing in the Market for Anticancer Drugs.(2015) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 46 | paper | |
| 2025 | The Economics of Generic Drug Shortages: The Limits of Competition In: Journal of Economic Perspectives. [Full Text][Citation analysis] | article | 1 |
| 2012 | How do Initial Signals of Quality Influence the Diffusion of New Medical Products? The Case of New Cancer Drug Treatments In: Advances in Health Economics and Health Services Research. [Full Text][Citation analysis] | chapter | 0 |
| 2024 | Stockpiling at the Onset of the COVID-19 Pandemic: An Empirical Analysis of National Prescription Drug Sales and Prices In: Management Science. [Full Text][Citation analysis] | article | 1 |
| 2009 | Early Retirement and DI/SSI Applications: Exploring the Impact of Depression In: NBER Chapters. [Full Text][Citation analysis] | chapter | 0 |
| 2016 | Specialty Drug Prices and Utilization after Loss of U.S. Patent Exclusivity, 2001–2007 In: NBER Chapters. [Full Text][Citation analysis] | chapter | 6 |
| 2014 | Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007.(2014) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 6 | paper | |
| 2006 | Early Retirement and Public Disability Insurance Applications: Exploring the Impact of Depression In: NBER Working Papers. [Full Text][Citation analysis] | paper | 12 |
| 2011 | The Effect of FDA Advisories on Branded Pharmaceutical Firms Valuations and Promotion Efforts In: NBER Working Papers. [Full Text][Citation analysis] | paper | 1 |
| 2017 | The Landscape of US Generic Prescription Drug Markets, 2004-2016 In: NBER Working Papers. [Full Text][Citation analysis] | paper | 11 |
| 2017 | The Generic Drug User Fee Amendments: An Economic Perspective In: NBER Working Papers. [Full Text][Citation analysis] | paper | 1 |
| 2019 | Four Facts Concerning Competition in U.S. Generic Prescription Drug Markets In: NBER Working Papers. [Full Text][Citation analysis] | paper | 5 |
| 2020 | Four Facts Concerning Competition in US Generic Prescription Drug Markets.(2020) In: International Journal of the Economics of Business. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 5 | article | |
| 2019 | The Surprising Hybrid Pedigree of Measures of Diversity and Economic Concentration In: NBER Working Papers. [Full Text][Citation analysis] | paper | 2 |
| 2019 | The Geography of Prescription Pharmaceuticals Supplied to the U.S.: Levels, Trends and Implications In: NBER Working Papers. [Full Text][Citation analysis] | paper | 1 |
| 2020 | Valuing Rare Pediatric Drugs: An Economics Perspective In: NBER Working Papers. [Full Text][Citation analysis] | paper | 2 |
| 2021 | Estimating the Financial Impact of Gene Therapy in the U.S. In: NBER Working Papers. [Full Text][Citation analysis] | paper | 1 |
| 2021 | Common Agent or Double Agent? Pharmacy Benefit Managers in the Prescription Drug Market In: NBER Working Papers. [Full Text][Citation analysis] | paper | 2 |
| 2010 | Personalized Medicine and Genomics: Challenges and Opportunities in Assessing Effectiveness, Cost-Effectiveness, and Future Research Priorities In: Medical Decision Making. [Full Text][Citation analysis] | article | 4 |
| 2020 | Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US In: PharmacoEconomics. [Full Text][Citation analysis] | article | 0 |
| 2020 | Reply to Comment on “Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US” In: PharmacoEconomics. [Full Text][Citation analysis] | article | 0 |
| 2016 | THE ADVANTAGES OF AWARDING THE FEDERAL GOVERNMENT NEGOTIATING POWER OVER THE PRICES OF PRESCRIPTION DRUGS In: Journal of Policy Analysis and Management. [Full Text][Citation analysis] | article | 0 |
| 2016 | RESPONSE TO JOYCE AND SOOD In: Journal of Policy Analysis and Management. [Full Text][Citation analysis] | article | 0 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 20 2025. Contact: CitEc Team